关注
Fatemeh Safari
Fatemeh Safari
在 sums.ac.ir 的电子邮件经过验证
标题
引用次数
引用次数
年份
CRISPR Cpf1 proteins: structure, function and implications for genome editing
F Safari, K Zare, M Negahdaripour, M Barekati-Mowahed, Y Ghasemi
Cell & bioscience 9, 1-21, 2019
1802019
Overview of albumin and its purification methods
R Raoufinia, A Mota, N Keyhanvar, F Safari, S Shamekhi, J Abdolalizadeh
Advanced pharmaceutical bulletin 6 (4), 495, 2016
1502016
Immunotoxins in cancer therapy: Review and update
B Akbari, S Farajnia, S Ahdi Khosroshahi, F Safari, M Yousefi, ...
International reviews of immunology 36 (4), 207-219, 2017
1402017
CRISPR and personalized Treg therapy: new insights into the treatment of rheumatoid arthritis
F Safari, S Farajnia, M Arya, H Zarredar, A Nasrolahi
Immunopharmacology and immunotoxicology 40 (3), 201-211, 2018
602018
CRISPR system: a high-throughput toolbox for research and treatment of Parkinson’s disease
F Safari, G Hatam, AB Behbahani, V Rezaei, M Barekati‑Mowahed, ...
Cellular and molecular neurobiology 40, 477-493, 2020
572020
CRISPR systems: Novel approaches for detection and combating COVID-19
F Safari, M Afarid, B Rastegari, A Borhani-Haghighi, M Barekati-Mowahed, ...
Virus Research 294, 198282, 2021
552021
The interaction of phages and bacteria: the co-evolutionary arms race
F Safari, M Sharifi, S Farajnia, B Akbari, M Karimi Baba Ahmadi, ...
Critical reviews in biotechnology 40 (2), 119-137, 2020
552020
Critical Micrornas in Lung Cancer: Recent Advances and Potential Applications.
FS Zarredar H, Ansarin K, Baradaran B, Shekari N, Eyvazi S, Safari F
Anticancer Agents Med Chem 18 (14), 1991-2005, 2018
37*2018
Strategies for Improving siRNA-Induced Gene Silencing Efficiency
F Safari, SR Barouji, AM Tamaddon
Advanced pharmaceutical bulletin, 2017
312017
Immune system and new avenues in Parkinson’s disease research and treatment
A Nasrolahi, F Safari, M Farhoudi, A Khosravi, F Farajdokht, ...
Reviews in the Neurosciences 30 (7), 709-727, 2019
252019
Immunotoxins and nanobody-based immunotoxins: Review and update
MR Khirehgesh, J Sharifi, F Safari, B Akbari
Journal of drug targeting 29 (8), 848-862, 2021
242021
New Developments in CRISPR Technology: Improvements in Specificity and Efficiency
F Safari, S Farajnia, Y Ghasemi, N Zarghami
242017
EGFR and anti-EGFR nanobodies: review and update
J Sharifi, MR Khirehgesh, F Safari, B Akbari
Journal of drug targeting 29 (4), 387-402, 2021
232021
Polyelectrolyte complexes of hTERT siRNA and polyethyleneimine: effect of degree of PEG grafting on biological and cellular activity
F Safari, AM Tamaddon, N Zarghami, S Abolmali, A Akbarzadeh
Artificial cells, nanomedicine, and biotechnology 44 (6), 1561-1568, 2016
232016
Targeting the KRAS, p38α, and NF‐κB in lung adenocarcinoma cancer cells: The effect of combining RNA interferences with a chemical inhibitor
H Zarredar, S Pashapour, S Farajnia, K Ansarin, B Baradaran, ...
Journal of Cellular Biochemistry 120 (6), 10670-10677, 2019
222019
Knockout of caspase-7 gene improves the expression of recombinant protein in CHO cell line through the cell cycle arrest in G2/M phase
F Safari, B Akbari
Biological research 55, 2022
132022
SEROTONERGIC SYSTEM MODULATION HOLDS PROMISE FOR L‐DOPA‐INDUCED DYSKINESIAS IN HEMIPARKINSONIAN RATS: A SYSTEMATIC REVIEW
JM Fereshteh Farajdokht1, 2, Saeed Sadigh-Eteghad2, Alireza Majdi2, Fariba ...
EXCLI Journal 19, 268-295, 2020
132020
Caspase-7 deficiency in Chinese hamster ovary cells reduces cell proliferation and viability
F Safari, S Farajnia, AB Behbahani, H Zarredar, M Barekati-Mowahed, ...
Biological Research 53, 2020
122020
Multiplex genome editing in chinese hamster ovary cell line using all-in-one and HITI CRISPR technology
F Safari, S Farajnia, Y Ghasemi, N Zarghami, MB Mowahed
Advanced Pharmaceutical Bulletin 11 (2), 343, 2021
82021
Direct Cloning, Expression and Purification of Human Activated Thrombin in Prokaryotic System and CD Analysis Report of Produced Thrombin: Molecular Characterization of …
A Barkhordari, A Behzad-Behbahani, V Jajarmi, M Bandehpour, ...
International Journal of Peptide Research and Therapeutics 26, 2661-2673, 2020
32020
系统目前无法执行此操作,请稍后再试。
文章 1–20